ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment

por Rivero, Rocio, Esteva, Mónica Inés, Huang, Erya, Colmegna, Leylen, Altcheh, Jaime, Grossmann, Ulrike, Ruiz, Andrés Mariano
Publicado 2023

Diagnostic Accuracy of Two Molecular Tools for Diagnosis of Congenital Chagas Disease

por Bisio, Margarita María Catalina, Rivero, Rocío, Gonzalez, Nicolás, Ballering, Griselda, D’Amico, Indira, Kessler, Camila, Moroni, Samanta, Moscatelli, Guillermo, Ruiz, Andrés Mariano, Altcheh, Jaime
Publicado 2021

Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus

por Alonso-Padilla, Julio, Abril, Marcelo, Alarcón de Noya, Belkisyolé, Almeida, Igor C., Angheben, Andrea, Araujo Jorge, Tania, Chatelain, Eric, Esteva, Monica, Gascón, Joaquim, Grijalva, Mario J., Guhl, Felipe, Hasslocher-Moreno, Alejandro Marcel, López, Manuel Carlos, Luquetti, Alejandro, Noya, Oscar, Pinazo, María Jesús, Ramsey, Janine M., Ribeiro, Isabela, Ruiz, Andres Mariano, Schijman, Alejandro G., Sosa-Estani, Sergio, Thomas, M. Carmen, Torrico, Faustino, Zrein, Maan, Picado, Albert
Publicado 2020